TrialScientific reports2022

Extended infusion of piperacillin-tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study.

Christina Medhat Naiim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.